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Objective: To achieve a better understanding in how university students live with
and are able to manage their type 1 diabetes (T1D).
Methods: In 2018, all fulltime Norwegian students aged 18 to 35 years pursuing
higher education were invited into a national survey, which included data on demo-
graphics and health. In all, 162 512 students fulfilled these inclusion criteria. Students
that stated having diabetes were asked to answer further questions about their
diabetes care.
Results: We included data from 50 054 students responding to the survey, and iden-
tified 324 students with T1D (64% females, mean age 23 years, mean HbA1c 7.65%
[60 mmol/mol]). Male students had a lower HbA1c (7.28% vs 7.86%, 56 vs 62 mmol/
mol), reached an HbA1c of <7.5% (58 mol/mol) more often (62.2% vs 44.2%) and
were using continuous glucose measurement (CGM) less often (19.5% vs 36.7%).
Exercise and smoking habits in students with T1D were equal to the non-diabetic
group. More students with T1D were overweight or obese (44.1% vs 32.2%). Stu-
dents who achieved an HbA1c <7.5% (58 mmol/mol) measured their blood sugar
more often, had a lower body-mass index, exercised more and were smoking less. An
HbA1c >7.5% (58 mmol/mol) was associated with less activity, more overweight or
obesity, and smoking. The use of continuous subcutaneous insulin infusion and CGM
was not associated with a better metabolic control.
Conclusions: These data have implications for the follow-up of adolescents and
young adults, showing the need to focus on general lifestyle habits, especially in
female subjects, whereas the use of technical devices might be of secondary
importance.
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1 | INTRODUCTION
Type 1 diabetes is a chronic disease that is demanding, like no other
disease, a lifelong, continuous and high effort by the person with diabe-
tes, eventual caregivers and support network. In order to keep blood
glucose stable, students with type 1 diabetes have to assess a complex
variety of many factors for example, carbohydrate intake and physical
activity. Lack of metabolic control, resulting in too low or too high blood
glucose, may cause both serious acute incidents and long-term compli-
cations. A major goal in the treatment of type 1 diabetes is the avoid-
ance of these acute incidents and long-term complications. Glycosylated
hemoglobin A1c (HbA1c) is a marker reflecting the glucose control over
a longer period, and therefore routinely used during the follow-up of
persons with diabetes. The International Society of Pediatric and Ado-
lescent Diabetes (ISPAD) has defined the new treatment target for
HbA1c as <53 mmol/mol (7.0%) in 2018.1 However, most children and
adolescents with type 1 diabetes do not meet this HbA1c target,
according to data from national and international diabetes registries.1-5
The incidence of type 1 diabetes has been increasing worldwide
by 2.8% to 3.4% over the last decades.6-9 This trend is also expected
to continue in the future. Norway has one of the highest incidences
of type 1 diabetes in the world, with an incidence rate of 37.9 per
100.000 person years in children and adolescents under 15 years.10
Pediatric diabetes care in Norway is solely given at hospitals with
pediatric departments, and documented in detail in the Norwegian
Childhood Diabetes Registry (NCDR).10 Aside from metabolic control,
the importance of healthy life style habits, such as non-smoking and
physical activity, are an inherent part of the follow-up appointments
in pediatric and adolescent care. There is more variation in the struc-
ture of adult diabetes care. It can be given both in primary and sec-
ondary health care, and has a lower proportion of reporting to the
Norwegian Diabetes Register for Adults (NDV). Glycemic control
often deteriorates during adolescence and emerging adulthood.11,12
Therefore, the transition from pediatric to adult care is of major
importance.13 Most Norwegian pediatric departments follow up their
patients until the age of 18, and have a structured transition from
pediatric to adult care when the patient is turning 18.
Norway is a highly developed welfare state, both in terms of
access to education and health care. Public universities provide educa-
tion free of tuition fees, and the Norwegian State Educational Loan
Fund provides loans and grants to all students in order to give the
same possibilities for education, regardless of economic and social
background, age, gender, and physical disabilities. Patients in Norway
pay only a limited contribution of approximately $200 per year for the
sum of all required medical expenses. The Norwegian health care sys-
tem covers eventual costs for medical consultations and treatment
exceeding this amount.
In 2018, the SHoT2018 study (Students' Health and Wellbeing
Study) was conducted as a cross-sectional national survey of all stu-
dents pursuing higher education in Norway.14 The overall aim of the
SHoT study was to examine the prevalence and trends across a range
of health problems and life challenges among college and university
students. Since diabetes has a high prevalence in Norway, it was also
part of the survey to illuminate the specific challenges and concerns
of students with diabetes.
To our knowledge, there are no specific studies published about
the life of university students with type 1 diabetes. The aim of our
study was to investigate how university students, who have qualified
for a higher education and in a system with liberal access to both edu-
cation, study loans and public health care, live with and are able to
manage their type 1 diabetes.
We hypothesized that there would be positive outcomes regard-
ing metabolic control as reflected by HbA1c, frequency of blood glu-
cose measurements and meaningful use of insulin pumps and
continuous glucose measurement (CGM), independent of the stu-
dents' gender. As the importance of a healthy life style is emphasized
during the continuous follow-up in pediatric diabetes care, we further
hypothesized that students with type 1 diabetes would have a health-
ier lifestyle, including frequent physical activity, normal body-mass
index (BMI), and non-smoking than their peers without diabetes.
2 | METHODS
2.1 | Procedure
The SHoT2018 study is a national student survey for higher education
in Norway, initiated by the three largest student welfare organizations
(Sammen [Bergen and surrounding area], Sit [Trondheim and surround-
ing area], and SiO [Oslo and Akershus]). In the SHoT2018 study, data
were collected electronically through a web-based platform. Details of
the study have been published elsewhere.14 Briefly, the SHoT2018 was
conducted between 6 February 2018 and 5 April 2018, and invited all
fulltime Norwegian students aged 18 to 35 years pursuing higher edu-
cation (both in Norway and abroad) to participate. In all, 162 512 stu-
dents fulfilled these inclusion criteria, of whom 50 054 students
completed the online questionnaires, yielding a response rate of 30.8%.
The average time spent answering the questionnaire was 21 minutes.
Although some universities and colleges allocated time in school classes
allowing the student to complete the survey during a lecture, no
teachers were instructed to provide support or assistance.
2.2 | Instruments
Students participating in the survey were asked to answer several ques-
tionnaires, which included detailed information on for example, demo-
graphics, health and health behavior and, if relevant, diabetes care.
2.3 | Demographic information
All participants indicated their gender and age, and participants were
also asked about their relationship status (response options: “single”,
“girl-/boyfriend”, “cohabitant”, and “married/registered partner”), as
well as their accommodation status (response options: “living alone”,
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“living with partner”, “living with friends/others in a collective”, and
“living with parents”). Financial difficulties were addressed with the
following question: “Has it happened during the past 12 months that
you/your household has had difficulty coping with the running costs,
for example for food, transport, and housing?” (Response options:
“never”, “rarely”, “sometimes”, and “often”). Finally, participants were
categorized as an immigrant if either the student or his/her parents
were born outside of Norway.
2.4 | Health behaviors
The students were first presented the following brief definition of phys-
ical exercise: “With exercise we mean that you, for example, go for a
walk, go skiing, swim, or take part in a sport”. Physical activity was then
assessed using three sets of questions, assessing the average number
of times exercising each week, and the average intensity and average
hours each time15: (a) “How frequently do you exercise?” (Never, less than
once a week, once a week, 2-3 times per week, Almost every day);
(b) “If you do such exercise as frequently as once or more times a week:
How hard do you push yourself? (I take it easy without breaking into a
sweat or losing my breath, I push myself so hard that I lose my breath
and break into a sweat, I push myself to near-exhaustion); and (c) “How
long does each session last?” (Less than 15 minutes, 15-29 minutes,
30 minutes to 1 hour, More than 1 hour”. This 3-item questionnaire
has previously been used in the large population-based Nord-Trøndelag
Health Study (the HUNT studies). Previous validation studies15,16 have
demonstrated moderate correlations between the questionnaire
responses and direct measurement of VO2max during maximal work on
a treadmill (r = 0.43[frequency], r = 0.40 [intensity], and r = 0.31 [dura-
tion]), with ActiReg,17,18 an instrument that measures PA and energy
expenditure (EE), in addition to the International Physical Activity Ques-
tionnaire.19 Based on WHO's recommendation20 that adults
(≥18 years) should get at least 30 minutes of moderate-intensity and
vigorous-intensity physical activity (MVPA) 5 days or more per week
(=150 min/wk),20 a dichotomous recommendation variable was created
based on the students' responses on all three exercise items: (a) MVPA:
150 min/wk: students answering both “Almost every day” on the fre-
quency item, “I push myself so hard that I lose my breath and break into
a sweat” on the intensity item, and “30 minutes or more” or “More than
1 hour” on the duration item.
BMI was calculated based on self-reported body weight
(kg) divided by squared height (m2).21,22 The BMI was then split into
three categories: normal/underweight (BMI <24.9), overweight (BMI
25.0-29.9), and obesity (BMI ≥30).23 Smoking was assessed with the
following question “Do you smoke?” (Response options: “yes, daily”,
“yes, sometimes”, and “no”.
2.5 | Diabetes-related characteristics
Physical conditions were assessed by a predefined list adapted to fit
this age cohort, which also included “diabetes”. The list was based on
a similar operationalization used in previous large population-based
studies (the HUNT study24) and included several subcategories for
most conditions/disorders (not listed here). If the student indicated
“yes” for diabetes, several additional questions were asked:
1. State the type of diabetes you have (response options: “Type 1 dia-
betes”, “Type 2 diabetes”, “Gestational Diabetes”, “LADA”,
“MODY”, and “Do not know/unsure”). Only students indicating
“Type 1 diabetes” were included in the current study, due to small
numbers in the remaining categories.
2. What was your last HbA1c value (long-term blood sugar)?
(Response options were provided in a drop-down list ranging from
4.0% to 14.9% in 0.1-intervals).
3. Which of the following aids/medications do you use? (Response
options [several responses possible]: “Insulin pen”, “Insulin pump”,
“Continuous Glucose Monitor (CGM)”, and “Flash devices (eg,
FreeStyle Libre)”.
4. “How often do you measure your blood sugar?” (Response options:
“never/a few times a month”, “several times a week, but not daily”,
and “daily”. If the response was “daily”, the following question was
asked: “Indicate how many times per day you measure your blood
sugar:” (response options were provided in a drop-down list rang-
ing from “1” to “10 or more”).
2.6 | Statistics
IBM SPSS version 26 (SPSS Inc., Chicago, Illinois) for Mac was used
for all analyses. Pearson chi-square tests were used to examine possi-
ble demographical (sex, age, marital status, accommodation status,
financial difficulties, and immigrant status) and health behavior (BMI,
exercise frequency, and smoking) differences between students with
and without type 1 diabetes. Independent samples t tests and Pearson
chi-squared tests were used to investigate gender differences in
diabetes-related characteristics, as well as differences in demographic,
health behaviors, and diabetes-related characteristics in students with
type 1 diabetes at or above target level (HbA1C ≥53 mmol/mol, 7.5%)
compared to those below. Estimated marginal means (EMM) for
HbA1c was calculated controlling for diabetes age of onset and sex.
There was generally little missing data, and hence missing values were
handled using a list wise deletion. As the SHoT2018 study had several
objectives and was not designed to be a study of students with T1D
specifically, no a priori power calculations were conducted to ensure
that the sample size had sufficient statistical power to detect differ-
ences in outcomes.
2.7 | Ethics
The SHoT2018 study was approved by the Regional Committee for
Medical and Health Research Ethics in Norway (no. 2017/1176). An
electronic informed consent was obtained after the participants had
received a detailed introduction to the study.
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3 | RESULTS
3.1 | Sample characteristics
The sample comprised 50 054 young adults (69.1% women), with a
mean age of 23.2 years (SD = 3.3). In all, 373 students (0.7%) reported
having diabetes, of which the large majority (87.6%; n = 324) had type
1 diabetes. The other types of diabetes were excluded from the cur-
rent study (type 2 diabetes [n = 33], gestational diabetes [n = 1],
LADA [n = 4], MODY [n = 5], and “do not know”/missing [n = 7]). The
prevalence of type 1 diabetes was significantly higher among male
students (0.8%, n = 116) compared to female students (0.6%, n = 206;
P = .046; see Table 1). As detailed in Table 1, there were no significant
differences between students with type 1 diabetes and the control
group with regard to age, marital status, accommodation status, and
financial difficulties. However, the proportion of immigrants was sig-
nificantly lower in the type 1 diabetes group compared to the control
group. In terms of health behaviors, the type 1 diabetes group did not
significantly differ from the control group for exercise frequency,
meeting the minimum recommended criteria for MVPA, or smoking
habits, whereas the proportion of overweight/obesity was signifi-
cantly higher among students with type 1 diabetes (see Table 1 for
details).
3.2 | Diabetes-related characteristics
The average HbA1c in the type 1 diabetes group was 60 mmol/mol
(7.65%), and significantly higher among females (62 mmol/mol, 7.86%)
compared to males (56 mmol/mol, 7.28%) (see Table 2 for details).
The mean age at diabetes onset was 12 years (SD = 5.60; no gender
differences). In terms of insulin delivery, 57.2% reported using an
insulin pen (multiple daily injections [MDI]) and 46.5% an insulin pump
(continuous subcutaneous insulin infusion [CSII]) (no gender differ-
ences). In terms of glucose control, 30.5% reported using CGM (men:
36.7%, women: 19.5%, P = .001), and 10.8% reported using a flash
glucose monitor (FGM, Freestyle Libre).
The large majority of the type 1 diabetes group (86.4%) reported
measuring their blood glucose level on a daily basis, while 8.7% and
5.0% reported measuring their blood glucose only “several times a
week” and “a few times a month/never”, respectively. Among those
measuring their blood glucose level on a daily basis, the average num-
ber of measurements was 5.21 (SD = 2.55), with no differences
between male and female students.
3.3 | Characteristics of students achieving the
HbA1c target
At the time of data collection, an HbA1c under 58 mmol/mol (7.5%)
was the recommended treatment goal from ISPAD. We therefore cat-
egorized our study sample into students reporting an HbA1c value
under 58 mmol/mol (7.5%) and students with an HbA1c of 58 mmol/
mol (7.5%) or higher. A significantly larger proportion of male students
(62.2%) reported an HbA1c below 58 mmol/mol (7.5%) compared to
female students (44.2%; P = .002), while there were no differences in
terms of age, marital status or accommodation status. Students
achieving the HbA1c target were also characterized by less financial
difficulties (P = .030), and being of Norwegian ethnicity (P = .057).
Regarding health behaviors, achieving the HbA1c target was associ-
ated with lower BMI, more frequent physical exercise, meeting
WHO's minimum criteria for MPVA, and not smoking cigarettes (see
Table 3 for details). In terms of diabetes-related characteristics,
achieving the HbA1c target was associated with older age at diabetes
onset (P = .006), and more frequent measurements of their blood glu-
cose level. There were no significant differences between students
achieving vs not achieving the HbA1c target with regard to the usage
of CGM. The students achieving an HbA1c of <58 mmol/mol (7.5%)
used an insulin pump in 39.5%, while those not achieving the target
were using an insulin pump in 54.9%.
The average HbA1c adjusted for age at diabetes onset and gen-
der are displayed in Figure 1. The adjusted HbA1c was significantly
lower among men (56 mmol/mol, 7.30%) than among women
(62 mmol/mol, 7.86%), while no significant differences were observed
for age, or marital, accommodation or immigrant status. Financial diffi-
culties were associated with HbA1c in a dose-response manner: the
more difficulties, the higher the HbA1c. A similar graded association
was also observed for exercise frequency: the more exercise, the
lower the HbA1c. Usage of different devices such as CSII, CGM, or
FGM was not significantly associated with HbA1c, whereas frequency
of testing was (see Figure 1 for details).
4 | DISCUSSION
In this national student survey for higher education in Norway, we
examined how students with type 1 diabetes lived with and managed
their diabetes. We found noteworthy gender aspects, such as better
HbA1c control and lower usage of CGM in male students. Students
with type 1 diabetes did not report higher levels of physical activity,
or smoking less, as one would wish, compared with the healthy con-
trol group. Students with type 1 diabetes were more likely to be over-
weight or obese than their healthy peers.
Among the strengths of the current study is the relatively large
group of students with type 1 diabetes, and in addition a large group
of healthy controls. In addition, students can study in Norway without
major economic barriers, and have broad access to excellent health
care. This gives us insights into a how young adults with diabetes cope
under quite optimal circumstances. Some study limitations should be
noted. First, the response rate was relatively modest (31%), and we
had little information about the characteristics of non-participants
beyond age and gender distribution. It has been shown that non-
participants of health surveys, in general have worse health than
participants,25 and as such, the current results may represent an
underestimation of the true prevalence of diabetes in the target popu-
lation. However, the prevalence of students with type 1 diabetes in
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our cohort (324/50 054 = 0.65%) was as expected, and in line with
the prevalence of 0.65% in the Norwegian population.26 Also, the dif-
ferent percentage of male vs female students with type 1 diabetes
(0.8% vs 0.6%) reflects the difference in incidence as reported in the
NCDR.10 Therefore, a possible selection bias due to over- or
underreporting seems unlikely. Related to this issue is the 69% female
composition of the sample, which may represent a bias for the overall
estimates, as females generally report worse health across most self-
TABLE 1 Demographical characteristics in student with and without type 1 diabetes
No diabetes (n = 49 981, 99.4%) Type 1 diabetes (n = 324, 0.6%)
Pearson chi-square (df) P-values
Sex % (n) % (n) χ2 = 3.987 (1) .046
Women 69.1% (34201) 64.0% (206)
Men 30.9% (15270) 36.0% (116)
Age group χ2 = 6.229 (4) .183
18-20 y 17.9% (8758) 20.8% (67)
21-22 y 31.4% (15356) 33.5% (108)
23-25 y 32.2% (15793) 31.1% (100)
26-28 y 11.6% (5682) 7.8% (25)
29-35 y 6.9% (3385) 6.8% (22)
Marital status χ2 = .047 (1) .829
Single 50.0% (24800) 50.6% (164)
Married/partner/girl- or boyfriend 50.0% (24786) 49.4% (160)
Accommodation status χ2 = 4.076 (3) .253
Alone 18.3% (9074) 22.2% (72)
With partner 27.4% (13559) 24.1% (78)
With friends/others in a collective 46.0% (22825) 45.1% (146)
With parents 8.3% (4109) 8.6% (28)
Financial difficulties χ2 = 3.197 (2) .202
Never 47.6% (23566) 50.2% (162)
Seldom 22.8% (11278) 18.6% (60)
Sometimes/often 29.7% (14710) 31.3% (101)
Immigrant status χ2 = 5.045 (1) .025
Ethnic Norwegian 92.0% (45696) 95.4% (309)
Immigrant 8.0% (3988) 4.6% (15)
BMI category χ2 = 20.415 (2) <.001
Normal/underweight (BMI <24.9) 67.8% (32606) 55.9% (176)
Overweight (BMI 25-29.9) 23.4% (11266) 32.4% (102)
Obese (BMI ≥30) 8.8% (4217) 11.7% (37)
Frequency exercise χ2 = 4.176 (3) .243
<1 x/wk 16.8% (8332) 16.5% (53)
1 x/wk 15.8% (7824) 18.3% (59)
2-3 x/wk 43.8% (21654) 38.8% (125)
Almost every day 23.6% (11660) 26.4% (85)
MVPA: 150 min/wk χ2 = 0.885 (1) .192
No 80.5% (39983) 78.4% (254)
Yes 19.5% (9701) 21.6% (70)
Smoking χ2 = 2.905 (2) .234
Yes, daily 1.6% (796) 2.8% (9)
Yes, sometimes 8.5% (4147) 7.9% (25)
No 89.8% (43652) 89.3% (284)
Abbreviation: BMI, body-mass index; MVPA, moderate-intensity and vigorous-intensity physical activity.
BRATKE ET AL. 1587
reported health parameters compared to men. Still, as females consti-
tute about 70% of the student population in Norwegian colleges/
universities, at least up to a bachelor degree, this should not represent
a substantial bias in the current study. Finally, it should be noted that
all data in the current study were based on self-reported information,
which might result in a social desirability or recall bias.
After categorizing the sample by HbA1c, we see that students
with an Hba1c <58 mmol/mol (7.5%) have a rather low mean Hba1c
(50 mmol/mol, 6.71%), whereas students with an HbA1c ≥58 mmol/
mol (7.5%) have a mean HbA1c of 70 mmol/mol (8.6%). Our cohort
seems to contain either very well regulated or quite badly regulated
subjects, which is not what we see in the pediatric population.
The overall metabolic control of the students reflected by the
mean HbA1c of the study sample was 60 mmol/mol (7.65%). Exercise
and smoking habits in students with type 1 diabetes were not differ-
ent compared to the healthy reference group. However, students
meeting the HbA1c target under 7.5% (58 mmol/mol) did reach the
MVPA recommendations significantly more often (Table 3). Further-
more, we found a large proportion of overweight and obesity in stu-
dents with type 1 diabetes (44.1% vs 32.2% in the healthy controls).
Students who achieved the HbA1c target of <58 mmol/mol (7.5%)
measured their blood sugar more often, had less financial difficulties,
a lower BMI, more physical activity and were smoking less. In con-
trast, those with worse metabolic control (HbA1c >58 mmol/mol,
7.5%) had even higher cardiac risks by being less active, more over-
weight (54.7%), and smoking (15.2%). The use of technical devices,
such as CSII and CGM, was relatively low compared to the pediatric
age group of under 18 years, as published recently in the NCDR (CSII:
46.5% vs 77.0%; CGM: 30.5% vs 65%.10 The use of CGM was not
associated with better metabolic control as reflected by lower HbA1c,
whereas there was a higher proportion of CSII use in the group not
achieving the HbA1c target.
4.1 | Gender aspects
Male students had a much lower mean HbA1c than female students,
and reached an HbA1c of <58 mmol/mol (7.5%) in a much higher pro-
portion. However, male students had a much lower usage of CGM
compared to female students. While female students are checking
their blood glucose as frequent as male students (mean 5.2 times
daily), the HbA1c result of the female group was much worse
(0.58 pp = 6 mmol/mol). This is critical, as mortality risk increases with
HbA1c (2% higher risk for each 1 mmol/mol increase in HbA1c,
equating to 12% in our cohort).27 For the future follow-up of the
young female age group, this implicates that clinicians have to make
recommendations that are more precise: frequently evaluating the
glucose level by either blood glucose measurements or CGM is per se
not helpful, as our results show. Former studies were suggesting that
the number of measurements per day was inversely associated with
HbA1c,28,29 which apparently is not true for our cohort. Actively
targeting toward a normal glucose level and taking insulin, conse-
quently, has to be more in focus, especially in female patients.
4.2 | Lifestyle habits
Students with type 1 diabetes did not have a more active lifestyle
than the control group. They had physical activity at least once a week
in 83.5% compared to 83.2% in the control group. Frequent training
was even less common in students with type 1 diabetes,
compared controls (2-3 x/week 43.8% vs 38.8%). However, 73.2% of
students with an HbA1c of <58 mmol/mol (7.5%) were training daily,
compared to 57% in the group with HbA1c >58 mmol/mol (7.5%).
Based on numerous studies, ISPAD recommends regular physical
activity in order to avoid micro- and macrovascular complications.30




Mean (SD) Mean (SD) Mean (SD)
Last HbA1c, % (mmol/mol) 7.86 (62) 1.42 (15) 7.28 (56) 0.94 (10) <.001 7.65 (60) 1.30 (14)
Age of onset, mean (SD) 11.92 (5.34) 12.04 (6.05) .853 11.99 (5.60)
Diabetes equipment
Insulin pen, % (n) 55.1% (114) 61.0% (72) .298 57.2% (186)
Insulin pump, % (n) 48.8% (101) 42.4% (50) .264 46.5% (151)
CGM, % (n) 36.7% (76) 19.5% (23) .001 30.5% (99)
Flash devices, % (n) 8.7% (18) 14.4% (17) .110 10.8% (35)
How often do you measure your blood sugar? % (n) .751
A few times a month/never 4.4% (9) 6.0% (7) 5.0% (16)
Several times a week 8.3% (17) 9.4% (11) 8.7% (28)
Daily 87.4% (180) 84.6% (99) 86.4% (3)
Daily measurements, mean (SD) 5.19 (2.64) 5.22 (2.38) .911 5.21 (2.55)
Abbreviation: CGM, continuous glucose monitor.
aDerived from independent samples t tests or Pearson chi-squared tests.
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HbA1c ≥58 mmol/mol (7.5%)
P-valueaMean/% (SD/n) Mean/% (SD/n)
Demographic characteristics
Sex .002
Women 44.2% (87) 55.8% (110)
Men 62.2% (69) 37.8% (42)
Age 22.98 (3.27) 23.00 (3.28) .959
Marital status .258
Single 54.1% (85) 47.7% (73)
Married or partner 45.9% (72) 52.3% (80)
Accommodation status .203
Alone 26.8% (42) 20.9% (32)
With partner 26.1% (41) 22.2% (34)
With friends/collective 41.4% (65) 45.8% (70)
With parents 5.7% (9) 11.1% (17)
Financial difficulties .030
Never 58.0% (91) 43.1% (66)
Seldom 16.6% (26) 20.3% (31)
Sometimes/often 25.5% (40) 36.6% (56)
Immigrant status .057
Ethnic Norwegian 51.9% (153) 48.1% (142)
Immigrant 26.7% (4) 73.3% (11)
Health behaviors
BMI category .005
Normal/underweight 63.9% 99 45.3% 67
Overweight 27.1% 42 39.2% 58
Obese 9.0% 14 15.5% 23
Frequency exercise <.001
<1 x/wk 13.4% 21 20.5% 31
1 x/wk 13.4% 21 22.5% 34
2-3 x/wk 36.3% 57 41.1% 62
Almost every day 36.9% 58 15.9% 24
MVPA: 150 min/wk <.001
No 70.3% (130) 87.4% (146)
Yes 29.7% (55) 12.6% (21)
Smoking .026
Daily 1.3% 2 4.6% 7
Sometimes 4.5% 7 10.6% 16
No 94.2% 145 84.8% 128
Diabetes-related characteristics
HbA1c % value, mean (SD) 6.71 (0.55) 8.60 (1.14) <.001
Age of onset, mean (SD) 12.86 (5.79) 11.11 (5.25) .006
Diabetes equipment
Insulin pen, % (n) 62.4% (98) 52.3% (80) .071
Insulin pump, % (n) 39.5% (62) 54.9% (84) .007
CGM, % (n) 28.0% (44) 35.3% (54) .169
(Continues)




HbA1c ≥58 mmol/mol (7.5%)
P-valueaMean/% (SD/n) Mean/% (SD/n)
Flash devices, % (n) 13.4% (21) 9.2% (14) .240
How often do you measure your blood sugar? % (n) .001
A few times a month/never 2.5% (4) 7.8% (12)
Several times a week 4.5% (7) 13.7% (21)
Daily 93.0% (146) 78.4% (120)
Daily measurements, mean (SD) 5.30 (2.64) 5.14 (2.51) .612
Abbreviations: BMI, body-mass index; CGM, continuous glucose monitor; MVPA, moderate-intensity and vigorous-intensity physical activity.
aDerived from independent samples t tests or Pearson chi-squared tests.
F IGURE 1 Estimated marginal means of HbA1c adjusted for age at diabetes onset and sex) by demographic factors, lifestyle behaviors and
diabetes-related characteristics. Note: p-values are based on overall Chi-squared tests, except for “Diabetes equipment” (which are compared to
not using that specific device [as the responses were not mutually exclusive])
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Moy et al showed that the activity level is inversely associated with
mortality risk,31 and Tikkanen et al showed that exercise, particularly
high frequency and high intensity exercise, may reduce the risk of car-
diovascular disease (CVD) events in patients with type 1 diabetes.32
De Lima et al showed that teenagers with type 1 diabetes had less
physical activity and less cardiorespiratory capacity than healthy con-
trols. Those teenagers with lower BMI z-score, who dedicated a
greater time in moderate-to-vigorous intensity physical activity, dem-
onstrated better glycemic control.33 Our data suggests that clinicians
still can improve in encouraging their young patients to regular physi-
cal activity, at least three times a week. However, smoking seems to
be a key confounder when evaluating the potential benefits of physi-
cal activity, and physical activity alone might not be as powerful in
preventing cardiovascular risks as formerly thought (27).
4.3 | Smoking
Unfortunately, 2.8% of the students with type 1 diabetes were smoking
daily, compared to only 1.6% in controls (P = .234). Students with a
higher HbA1c (>58 mmol/mol (7.5%)) were smoking daily in 4.6%, while
only 1.3% did in the group with good metabolic control (P = .026). Thus,
compared to international data, these rates are still rather low. Reynolds
et al reported data from the American SEARCH study, with a prevalence
of smoking of 2.7%/17.1%/34% smoking in the age groups of under
15, 15 to 19, and over 19 years of age, respectively. Less than 50% of
youth aged 10 to 14 years (52.2% of participants) reported having ever
been counseled by their healthcare provider not to smoke or to stop
smoking (27). Hofer et al showed a high prevalence of smoking of 5%
already in the 11- to 15-year-old age group, and 28.4% in the 15- to
20-year-old age group. The HbA1c was 76 mmol/mol (9.1%) in smoking
young with type 1 diabetes compared to 8.0% (64 mmol/mol) in non-
smokers. Both our own data, but also the results from these studies
confirm the high urgency of both regularly asking for smoking habits,
but also educating on the severe consequences of smoking for subjects
with type 1 diabetes, in order to prevent adolescents from smoking.
When recognizing a newly developed smoking habit, smoking cessation
should be addressed by the clinician, and supportive measures should
be recommended and offered. Still, there is very limited evidence on the
effect of smoking-cessation interventions in the adolescent age group,34
and we might need to learn better ways of addressing smoking.
4.4 | Overweight and obesity
Among students with type 1 diabetes, overweight and obesity were
more common than in healthy controls. Students with type 1 diabetes
and high HbA1c were more often overweight and obese, compared to
students with HbA1c <58 mmol/mol (7.5%). The relation between
BMI and CVD has been shown by numerous studies.35 In addition,
Csiege et al have recently described the association between sub-
optimal controlled HbA1c and obesity in a large study on adults with
type 1 diabetes (26). In contrast, Rawshani et al evaluated the relative
prognostic importance of different risk factors for mortality and car-
diovascular events, and showed that BMI was not within the most
important causes of death. However, their cohort had a BMI of
approximately 25 kg/m2 in all HbA1c groups.27 This differs signifi-
cantly from both our cohort and the results from Csiege (2018) men-
tioned above. We believe that monitoring BMI regularly, and
adjusting insulin treatment and lifestyle recommendations in order to
prevent overweight in youth with type 1 diabetes, is still of major
importance for the prevention of CVD.
The cohort of our study is a privileged group of young adults, living
and studying in a wealthy western country, and thereby not comparable
to any general population. One would wish and expect that subjects
with type 1 diabetes in this special cohort showed a healthier lifestyle,
compared to subjects without diabetes as a risk factor. It is concerning
to see the lacking or inadequate physical activity, high proportion of
overweight and obesity, smoking habits, and difference in HbA1c
related to gender. In female students, frequent measuring of blood glu-
cose does not translate into better HbA1c. The use of CSII or CGM was
not associated with a better metabolic control as reflected by lower
HbA1c. Our results supply valuable information for clinicians taking care
of youth and young adults with type 1 diabetes. The follow-up of this
age group should be adapted in order to reach better glucose control
and healthier lifestyle habits, especially in the female subjects. However,
the effective strategies to reach these goals have still to be explored.
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